✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
Vusion is a drug marketed by Mylan and is included in one NDA. There is one patent protecting this drug.
This drug has one patent family member in one country.
The generic ingredient in VUSION is miconazole nitrate; white petrolatum; zinc oxide. There are twenty-eight drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the miconazole nitrate; white petrolatum; zinc oxide profile page.
By analyzing the patents and regulatory protections it appears that the earliest date
for generic entry will be March 30, 2028. This may change due to patent challenges or generic licensing.
Indicators of Generic Entry
Summary for VUSION
|Finished Product Suppliers / Packagers:||1|
|Raw Ingredient (Bulk) Api Vendors:||103|
|Formulation / Manufacturing:||see details|
|Drug Prices:||Drug price information for VUSION|
|What excipients (inactive ingredients) are in VUSION?||VUSION excipients list|
|DailyMed Link:||VUSION at DailyMed|
DrugPatentWatch® Estimated Generic Entry Opportunity Date for VUSION
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for VUSION
Identify potential brand extensions & 505(b)(2) entrants
|Image Dermatology P.C.||Early Phase 1|
|Stiefel, a GSK Company||Phase 4|
Pharmacology for VUSION
|Drug Class||Azole Antifungal |
VUSION is protected by one US patents.
Based on analysis by DrugPatentWatch, the earliest date for a generic version of VUSION is See Plans and Pricing.
This potential generic entry date is based on patent See Plans and Pricing.
Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.
Patents protecting VUSION
Modified azole compounds as antifungal and antibacterial agents
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: USE FOR TREATMENT OF DIAPER DERMATITIS COMPLICATED BY CANDIDIASIS
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Mylan||VUSION||miconazole nitrate; white petrolatum; zinc oxide||OINTMENT;TOPICAL||021026-001||Feb 16, 2006||RX||Yes||Yes||See Plans and Pricing||See Plans and Pricing||See Plans and Pricing|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Patent No.||Patent Expiration|
|Mylan||VUSION||miconazole nitrate; white petrolatum; zinc oxide||OINTMENT;TOPICAL||021026-001||Feb 16, 2006||See Plans and Pricing||See Plans and Pricing|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>Patent No.||>Patent Expiration|
See the table below for patents covering VUSION around the world.
|Country||Patent Number||Title||Estimated Expiration|
|Philippines||20480||SKIN CARE COMPOSITIONS||See Plans and Pricing|
|Japan||H0676330||See Plans and Pricing|
|Ireland||58380||Skin care compositions||See Plans and Pricing|
|European Patent Office||0149561||SKIN CARE COMPOSITIONS||See Plans and Pricing|
|Singapore||66489||See Plans and Pricing|
|>Country||>Patent Number||>Title||>Estimated Expiration|